Physician profile
Diane Rother
NPI 1386935757
$10,518.52
in general payments reported to CMS, 2019-2025
51 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,826 · 2022: $1,986 · 2023: $2,282 · 2024: $2,255 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,706.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,584.80 | 2021-2025 | |
| Pfizer INC. | $1,175.67 | 2021-2025 | |
| Novo Nordisk INC | $813.17 | 2021-2025 | Wegovy |
| Lilly USA, LLC | $752.40 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Glaxosmithkline, LLC. | $724.97 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $628.83 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Abbott Laboratories | $340.89 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.12 | 2021-2024 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Merck Sharp & Dohme LLC | $275.70 | 2021-2024 | Verquvo, Belsomra, Steglatro |
| Amgen INC. | $272.20 | 2021-2024 | Evenity, Prolia, Repatha |
| Sanofi-Aventis U.S. LLC | $229.71 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $201.40 | 2022-2024 | |
| Axsome Therapeutics, INC. | $182.30 | 2023-2025 | Auvelity, Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.68 | 2021-2025 | Xifaxan |
| Almatica Pharma LLC | $153.58 | 2021-2025 | Loreev Xr, Gralise |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $144.82 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $129.04 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $106.89 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $102.49 | 2022-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $101.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $98.26 | 2021-2023 | Xarelto |
| Lundbeck LLC | $93.48 | 2022-2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $92.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $75.57 | 2021-2022 | |
| Astellas Pharma US INC | $73.84 | 2023-2025 | Veozah |
| Intra-Sana Laboratories | $72.09 | 2023-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Amarin Pharma, INC. | $70.98 | 2021-2022 | |
| Inspire Medical Systems, INC. | $63.84 | 2024-2025 | Inspire |
| Exact Sciences Corporation | $49.51 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biogen, INC. | $37.76 | 2021-2024 | Skyclarys |
| Xeris Pharmaceuticals, INC. | $35.14 | 2022-2023 | Gvoke Hypopen |
| Idorsia Pharmaceuticals US INC | $34.47 | 2023-2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $33.11 | 2022-2024 | Eliquis |
| Adlon Therapeutics L.P. | $27.24 | 2021 | |
| Sanofi Pasteur INC. | $24.27 | 2023 | |
| Verona Pharma, INC. | $23.85 | 2025 | Ohtuvayre |
| Grifols USA, LLC | $22.12 | 2024 | Xembify |
| Seqirus USA INC | $19.15 | 2024 | Fluad, Flucelvax |
| Tolmar, INC. | $19.10 | 2023 | |
| Impel Pharmaceuticals INC. | $18.19 | 2023 | Trudhesa |
| Genentech USA, INC. | $18.16 | 2021 | |
| Tonix Medicines, INC. | $15.97 | 2025 | Tonmya |
| Intuity Medical INC | $15.23 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Phadia US INC. | $14.84 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.56 | 2021 | |
| Althera Pharmaceuticals LLC | $13.46 | 2021 | |
| Eisai INC. | $13.32 | 2021 | |
| Medtronic, INC. | $13.21 | 2023 | Minimed 770g |
| Kowa Pharmaceuticals America, INC. | $13.18 | 2022 | |
| Leo Pharma INC. | $12.55 | 2021 | |
| Clarus Therapeutics INC. | $10.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Rother listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.